Task: Answer the multiple-choice question.
Query: Which drug exhibits a 1.212\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] CC(C)[C@H](NC(N)=O)C(=O)Nc1ccc2c(c1)CCC2
[b] O=C(NC12CC3CC(CC(C3)C1)C2)c1cc(F)c(F)c(F)c1F
[c] CC(=O)c1cc(C#N)c(Oc2cc(C)cc(C)c2)nc1C
Answer: a. CC(C)[C@H](NC(N)=O)C(=O)Nc1ccc2c(c1)CCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)[C@H](NC(N)=O)C(=O)Nc1ccc2c(c1)CCC2
CC(C)[C@H](NC(N)=O)C(=O)Nc1ccc2c(c1)CCC2
(2S)-2-(carbamoylamino)-N-(2,3-dihydro-1H-inden-5-yl)-3-methylbutanamide